Advisory Research’s Intellia Therapeutics NTLA Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-7,465	Closed	-$542K	–	413
2022 Q1	$542K	Buy	+7,465	New	+$542K	0.04%	242
2021 Q4	–	Sell	-3,053	Closed	-$410K	–	373
2021 Q3	$410K	Sell	3,053 -1,993	-39%	-$268K	0.03%	266
2021 Q2	$817K	Buy	+5,046	New	+$817K	0.05%	228